Targeted Therapy (Antibody / ADC)

8 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

+63 919 076 9100

Targeted Therapy (Antibody / ADC) (8)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Molecule	Drug Class / Mechanism	Oncology Type	Inquiry
Trastuzumab Deruxtecan	Anti-HER2 Agent	Solid Tumour (Breast/Gastric)
Molecule Trastuzumab Deruxtecan Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Pertuzumab	Anti-HER2 Agent	Solid Tumour (Breast/Gastric)
Molecule Pertuzumab Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Trastuzumab Emtansine (T-DM1)	Anti-HER2 Agent	Solid Tumour (Breast/Gastric)
Molecule Trastuzumab Emtansine (T-DM1) Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Disitamab Vedotin	Anti-HER2 Agent	Solid Tumour (Breast/Gastric)
Molecule Disitamab Vedotin Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Margetuximab	Anti-HER2 Agent	Solid Tumour (Breast/Gastric)
Molecule Margetuximab Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Trastuzumab	Anti-HER2 Agent	Solid Tumour (Breast/Gastric)
Molecule Trastuzumab Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Trastuzumab Duocarmazine	Anti-HER2 Agent	Solid Tumour (Breast/Gastric)
Molecule Trastuzumab Duocarmazine Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Zanidatamab	Anti-HER2 Agent	Solid Tumour (Breast/Gastric)
Molecule Zanidatamab Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent

Trastuzumab Deruxtecan Targeted Therapy (Antibody / ADC)
Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Pertuzumab Targeted Therapy (Antibody / ADC)
Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Trastuzumab Emtansine (T-DM1) Targeted Therapy (Antibody / ADC)
Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Disitamab Vedotin Targeted Therapy (Antibody / ADC)
Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Margetuximab Targeted Therapy (Antibody / ADC)
Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Trastuzumab Targeted Therapy (Antibody / ADC)
Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Trastuzumab Duocarmazine Targeted Therapy (Antibody / ADC)
Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent
Zanidatamab Targeted Therapy (Antibody / ADC)
Therapeutic Category Targeted Therapy (Antibody / ADC) Oncology Type Solid Tumour (Breast/Gastric) Drug Class / Mechanism Anti-HER2 Agent